Ion Beam Applications SA (IOBCF)
USD 14.05
(0.0%)
USD 14.05
(0.0%)
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2023 | -67.72 Million EUR | 42.36% |
| 2022 | -117.49 Million EUR | 9.82% |
| 2021 | -130.29 Million EUR | -99.87% |
| 2020 | -65.18 Million EUR | -406.24% |
| 2019 | 21.28 Million EUR | -56.9% |
| 2018 | 49.38 Million EUR | 219.09% |
| 2017 | 15.47 Million EUR | 134.65% |
| 2016 | -44.66 Million EUR | 10.75% |
| 2015 | -50.04 Million EUR | -845.24% |
| 2014 | -5.29 Million EUR | -129.19% |
| 2013 | 18.13 Million EUR | -35.84% |
| 2012 | 28.26 Million EUR | -34.43% |
| 2011 | 43.11 Million EUR | 57.91% |
| 2010 | 27.3 Million EUR | 343.45% |
| 2009 | -11.21 Million EUR | 37.02% |
| 2008 | -17.8 Million EUR | 44.4% |
| 2007 | -32.02 Million EUR | 27.2% |
| 2006 | -43.99 Million EUR | -140.45% |
| 2005 | -18.29 Million EUR | 20.67% |
| 2004 | -23.06 Million EUR | -253.84% |
| 2003 | 14.99 Million EUR | -88.79% |
| 2002 | 133.68 Million EUR | -31.68% |
| 2001 | 195.67 Million EUR | 0.0% |
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2024 Q2 | -27.74 Million EUR | 99.25% |
| 2024 Q1 | -27.74 Million EUR | 59.03% |
| 2023 Q3 | -73.82 Million EUR | -19.6% |
| 2023 Q2 | -61.72 Million EUR | 8.62% |
| 2023 Q1 | -67.55 Million EUR | 42.51% |
| 2023 Q4 | -67.72 Million EUR | 8.27% |
| 2023 FY | -67.72 Million EUR | 42.36% |
| 2022 Q1 | -143.28 Million EUR | -9.97% |
| 2022 Q4 | -117.49 Million EUR | 4.61% |
| 2022 FY | -117.49 Million EUR | 9.82% |
| 2022 Q3 | -123.17 Million EUR | 5.49% |
| 2022 Q2 | -130.33 Million EUR | 9.04% |
| 2021 Q4 | -130.29 Million EUR | 3.95% |
| 2021 Q3 | -135.65 Million EUR | -98.02% |
| 2021 Q1 | -73.31 Million EUR | -12.46% |
| 2021 FY | -130.29 Million EUR | -99.87% |
| 2021 Q2 | -68.5 Million EUR | 6.56% |
| 2020 Q1 | -8.41 Million EUR | -139.54% |
| 2020 Q2 | -3.76 Million EUR | 55.25% |
| 2020 Q3 | -72.58 Million EUR | -1827.3% |
| 2020 Q4 | -65.18 Million EUR | 10.19% |
| 2020 FY | -65.18 Million EUR | -406.24% |
| 2019 FY | 21.28 Million EUR | -56.9% |
| 2019 Q4 | 21.28 Million EUR | 29.66% |
| 2019 Q1 | 68.59 Million EUR | 38.89% |
| 2019 Q3 | 16.41 Million EUR | -77.29% |
| 2019 Q2 | 72.29 Million EUR | 5.4% |
| 2018 Q1 | 39.08 Million EUR | 152.55% |
| 2018 FY | 49.38 Million EUR | 219.09% |
| 2018 Q4 | 49.38 Million EUR | -17.1% |
| 2018 Q3 | 59.57 Million EUR | 52.41% |
| 2018 Q2 | 39.08 Million EUR | 0.0% |
| 2017 Q3 | 15.47 Million EUR | 173.11% |
| 2017 Q2 | -21.16 Million EUR | 0.19% |
| 2017 Q1 | -21.2 Million EUR | 52.51% |
| 2017 Q4 | 15.47 Million EUR | 0.0% |
| 2017 FY | 15.47 Million EUR | 134.65% |
| 2016 Q1 | -58.69 Million EUR | -17.29% |
| 2016 Q3 | -44.81 Million EUR | 23.46% |
| 2016 FY | -44.66 Million EUR | 10.75% |
| 2016 Q2 | -58.54 Million EUR | 0.25% |
| 2016 Q4 | -44.66 Million EUR | 0.34% |
| 2015 Q1 | -20.85 Million EUR | -293.9% |
| 2015 Q4 | -50.04 Million EUR | 0.41% |
| 2015 FY | -50.04 Million EUR | -845.24% |
| 2015 Q2 | -20.65 Million EUR | 0.97% |
| 2015 Q3 | -50.24 Million EUR | -143.31% |
| 2014 Q2 | -10.81 Million EUR | 0.0% |
| 2014 Q3 | -5.49 Million EUR | 49.15% |
| 2014 Q4 | -5.29 Million EUR | 3.69% |
| 2014 Q1 | -10.81 Million EUR | -159.61% |
| 2014 FY | -5.29 Million EUR | -129.19% |
| 2013 FY | 18.13 Million EUR | -35.84% |
| 2013 Q4 | 18.13 Million EUR | 1.15% |
| 2013 Q3 | 17.92 Million EUR | -71.26% |
| 2013 Q2 | 62.38 Million EUR | 0.45% |
| 2013 Q1 | 62.1 Million EUR | 119.71% |
| 2012 FY | 28.26 Million EUR | -34.43% |
| 2012 Q4 | 28.26 Million EUR | 166.52% |
| 2012 Q3 | -42.49 Million EUR | -199.87% |
| 2012 Q2 | 42.55 Million EUR | 0.0% |
| 2011 Q2 | 2.87 Million EUR | 0.0% |
| 2011 FY | 43.11 Million EUR | 57.91% |
| 2011 Q4 | 43.11 Million EUR | 0.0% |
| 2010 FY | 27.3 Million EUR | 343.45% |
| 2010 Q4 | 27.3 Million EUR | 0.0% |
| 2010 Q2 | 45.61 Million EUR | 0.0% |
| 2009 Q4 | -11.21 Million EUR | 0.0% |
| 2009 FY | -11.21 Million EUR | 37.02% |
| 2008 FY | -17.8 Million EUR | 44.4% |
| 2007 FY | -32.02 Million EUR | 27.2% |
| 2006 FY | -43.99 Million EUR | -140.45% |
| 2005 FY | -18.29 Million EUR | 20.67% |
| 2004 FY | -23.06 Million EUR | -253.84% |
| 2003 FY | 14.99 Million EUR | -88.79% |
| 2002 FY | 133.68 Million EUR | -31.68% |
| 2001 FY | 195.67 Million EUR | 0.0% |
| Name | Net Debt | Net Debt Difference |
|---|---|---|
| AVITA Medical, Inc. | -26.23 Million USD | -158.173% |
| Manhattan Scientifics, Inc. | -7000.00 USD | -967371.429% |
| Össur hf. | 395.08 Million USD | 117.142% |
| QHSLab, Inc. | 1.72 Million USD | 4014.692% |
| Wellstar International, Inc. | 51.36 Million USD | 231.842% |
| Össur hf. | 395.08 Million USD | 117.142% |
| CVR Medical Corp. | - USD | Infinity% |
| Bionovate Technologies Corp | - USD | Infinity% |
| Escalon Medical Corp. | 315.68 Thousand USD | 21552.646% |
| Aurora Spine Corporation | 1.9 Million USD | 3650.065% |
| BrainsWay Ltd. | -10.32 Million USD | -556.231% |
| Lattice Biologics Ltd. | - USD | Infinity% |
| BioElectronics Corporation | 14.82 Million USD | 556.768% |
| Hamilton Thorne Ltd. | 18.12 Million USD | 473.623% |
| Vivos Inc. | -1.59 Million USD | -4153.191% |
| Kelyniam Global, Inc. | 487.33 Thousand USD | 13996.658% |
| REMSleep Holdings, Inc. | -540.98 Thousand USD | -12418.439% |
| Zecotek Photonics Inc. | 2.76 Million USD | 2551.556% |
| Avitar, Inc. | 5.17 Million USD | 1409.63% |
| Nanomix Corporation | 11.38 Million USD | 694.627% |
| EKF Diagnostics Holdings plc | -4.61 Million USD | -1366.764% |
| Theraclion SA | -5.86 Million EUR | -1054.789% |
| Lifeline Biotechnologies, Inc. | - USD | Infinity% |
| Positron Corporation | 1.68 Million USD | 4114.69% |
| Rafina Innovations Inc. | - USD | Infinity% |
| Electromedical Technologies, Inc. | 1.61 Million USD | 4304.199% |
| Lombard Medical, Inc. | 11.49 Million USD | 689.152% |
| ALR Technologies Inc. | 19.14 Million USD | 453.677% |
| Stratec SE | 119.12 Million USD | 156.851% |
| Vycor Medical, Inc. | 1.05 Million USD | 6531.697% |
| Heart Tronics, Inc. | 54.99 Thousand USD | 123243.922% |
| MicroPort Scientific Corporation | 673.58 Million USD | 110.054% |
| VMS Rehab Systems, Inc. | 133.52 USD | 50721340.264% |
| NewCardio, Inc. | 2.41 Million USD | 2904.235% |
| Guided Therapeutics, Inc. | 1.46 Million USD | 4716.431% |
| Ingen Technologies, Inc. | 630.91 Thousand USD | 10834.024% |
| Odyssey Group International, Inc. | 2.1 Million USD | 3312.978% |
| CYduct Diagnostics, Inc. | 640.19 Thousand USD | 10678.463% |
| Wellness Center USA, Inc. | 3.98 Million USD | 1799.242% |
| SANUWAVE Health, Inc. | 30.14 Million USD | 324.643% |
| IR-Med Inc. | -606 Thousand USD | -11075.413% |
| Perimeter Medical Imaging AI, Inc. | -13.78 Million USD | -391.199% |
| Polarean Imaging plc | -5.94 Million USD | -1038.865% |
| United American Healthcare Corporation | -9.32 Million USD | -626.096% |
| ECGI Holdings, Inc. | 3.17 Million USD | 2235.535% |
| Nu-Med Plus, Inc. | 93.19 Thousand USD | 72768.841% |
| Capital Group Holdings, Inc. | -3508.00 USD | -1930430.217% |
| ADM Tronics Unlimited, Inc. | 262.61 Thousand USD | 25887.646% |
| Medical Supply International USA, Inc. | 216.6 Thousand USD | 31365.235% |
| Urologix, Inc. | 4.61 Million USD | 1567.454% |
| Rapid Therapeutic Science Laboratories, Inc. | 4.2 Million USD | 1708.843% |
| Nexeon MedSystems Inc. | 3.33 Million USD | 2132.962% |
| SS Innovations International, Inc. | 1.18 Million USD | 5813.358% |
| Qualis Innovations, Inc. | 6671.00 USD | 1015285.13% |
| Smith & Nephew plc | 2.77 Billion USD | 102.438% |
| NIOX Group Plc | -23.93 Million USD | -182.976% |
| Fuse Medical, Inc. | 1.75 Million USD | 3957.772% |
| Broncus Holding Corporation | -81.42 Million USD | 16.828% |
| Brain Scientific Inc. | 2.11 Million USD | 3300.866% |
| Pressure BioSciences, Inc. | 22.67 Million USD | 398.641% |
| Health Logic Interactive Inc. | 39.55 Thousand USD | 171303.58% |